Are adult patients more tolerant of treatment risks than parents of juvenile patients?
about
Assessing patient preferences for treatment options and process of care in inflammatory bowel disease: a critical review of quantitative dataLost in translation: helping patients understand the risks of inflammatory bowel disease therapy.Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis.Making therapeutic decisions in inflammatory bowel disease: the role of patients.Patient preferences for surgical versus medical therapy for ulcerative colitis.Vaccine message framing and parents' intent to immunize their infants for MMR.Real-time tool to display the predicted disease course and treatment response for children with Crohn's disease.A framework for organizing and selecting quantitative approaches for benefit-harm assessment.Balancing and communicating the risks and benefits of biologics in pediatric inflammatory bowel diseaseHow much risk are emergency department patients willing to accept to avoid diagnostic testing.Quantifying benefit-risk preferences for medical interventions: an overview of a growing empirical literature.Balancing benefit and risk of medicines: a systematic review and classification of available methodologies.Using Discrete Choice Experiments to Inform the Benefit-Risk Assessment of Medicines: Are We Ready Yet?Investigating heterogeneity in the characterization of risks using best worst scaling.Optimizing Selection of Biologics in Inflammatory Bowel Disease: Development of an Online Patient Decision Aid Using Conjoint Analysis.
P2860
Q26864906-3AA123E2-E57C-4AEE-853C-3BAE32918220Q30498145-70F8FF69-98A0-4FFA-A775-0AE7FE241EC8Q33756929-5CFBBD97-E56B-41FE-93E3-9CDA2ED03EDCQ33941262-CA8C850C-6AA6-4CED-86B9-E3D331DEB70EQ34065549-D1BAB884-562F-4AAC-B08F-2B1422D0DDA2Q34086726-0FB57DB4-FFD7-43C2-8C69-8418272F3B15Q34388523-17200C9F-A91E-49C4-9948-CA2D34726678Q34481196-F224D183-6186-4529-BA7B-F8E7ACB31FC8Q37609746-FAE0AE13-2B0B-4457-ACFD-E73CB81BF8A6Q37709813-47428D5A-371E-4D26-90DD-3C2431F65972Q38103514-7C6A5F9B-0A60-48C3-8204-6EE7E7A42C4FQ38211405-6369FF55-E894-4F03-9361-7E721B821D46Q38768040-02FD3D79-0B3D-47D2-A4E5-E70E41CFC7F3Q40087104-9BABA9C6-1591-4651-A1DB-930A0595CA2CQ50067204-6F4B79BA-35E6-4A67-9079-FE5BF385CC59
P2860
Are adult patients more tolerant of treatment risks than parents of juvenile patients?
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Are adult patients more tolerant of treatment risks than parents of juvenile patients?
@ast
Are adult patients more tolerant of treatment risks than parents of juvenile patients?
@en
type
label
Are adult patients more tolerant of treatment risks than parents of juvenile patients?
@ast
Are adult patients more tolerant of treatment risks than parents of juvenile patients?
@en
prefLabel
Are adult patients more tolerant of treatment risks than parents of juvenile patients?
@ast
Are adult patients more tolerant of treatment risks than parents of juvenile patients?
@en
P2093
P2860
P1433
P1476
Are adult patients more tolerant of treatment risks than parents of juvenile patients?
@en
P2093
Bruce E Sands
Carol Mansfield
Corey A Siegel
F Reed Johnson
Semra Ozdemir
Steven Hass
P2860
P304
P356
10.1111/J.1539-6924.2008.01135.X
P577
2008-09-26T00:00:00Z